ABBVNYSE

AbbVie Inc.

Pharmaceutical Preparationsยท SIC 2834

Total Filings Found
40
10-K, 10-Q, 8-K, DEF 14A

American pharmaceutical company

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

WikipediaWikidataSource: Wikipedia (CC BY-SA)
Ticker Symbol
ABBV
Exchange
NYSE
CIK Number
1551152
SIC Code
2834

Annual Reports (10-K)

FormDescriptionFiling DateDocument
10-K
Annual Report
Feb 20, 2026View
10-K
Annual Report
Feb 14, 2025View

Quarterly Reports (10-Q)

FormDescriptionFiling DateDocument
10-Q
Quarterly Report
Nov 4, 2025View
10-Q
Quarterly Report
Aug 4, 2025View
10-Q
Quarterly Report
May 9, 2025View
10-Q
Quarterly Report
Nov 4, 2024View
10-Q
Quarterly Report
Aug 7, 2024View
10-Q
Quarterly Report
May 3, 2024View

Other Filings

FormDescriptionFiling DateDocument
8-K
Current Report
Apr 29, 2026View
8-K
Current Report
Apr 3, 2026View
DEF 14A
Proxy Statement
Mar 23, 2026View
8-K
Current Report
FORM 8-K
Mar 4, 2026View
8-K
Current Report
FORM 8-K
Feb 26, 2026View
8-K
Current Report
Feb 4, 2026View
8-K
Current Report
Jan 7, 2026View
8-K
Current Report
Oct 31, 2025View
8-K
Current Report
Oct 3, 2025View
8-K
Current Report
FORM 8-K
Sep 11, 2025View
8-K
Current Report
Jul 31, 2025View
8-K
Current Report
Jul 3, 2025View
8-K
Current Report
FORM 8-K
May 13, 2025View
8-K
Current Report
Apr 25, 2025View
8-K
Current Report
Apr 3, 2025View
DEF 14A
Proxy Statement
Mar 24, 2025View
8-K
Current Report
FORM 8-K
Feb 26, 2025View
8-K
Current Report
FORM 8-K
Feb 19, 2025View
8-K
Current Report
FORM 8-K
Feb 14, 2025View
8-K
Current Report
FORM 8-K
Feb 5, 2025View
8-K
Current Report
Jan 31, 2025View
8-K
Current Report
Jan 10, 2025View
8-K
Current Report
Jan 6, 2025View
8-K
Current Report
FORM 8-K
Dec 13, 2024View
8-K
Current Report
Oct 30, 2024View
8-K
Current Report
Oct 3, 2024View
8-K
Current Report
FORM 8-K
Sep 10, 2024View
8-K
Current Report
Jul 25, 2024View
8-K
Current Report
Jul 3, 2024View
8-K
Current Report
Apr 26, 2024View
8-K
Current Report
Apr 3, 2024View
DEF 14A
Proxy Statement
Mar 18, 2024View

View all AbbVie Inc. filings on SEC EDGAR

The official SEC database contains the complete filing history

Open SEC EDGAR โ†’

Filing data sourced from SEC EDGAR โ€” U.S. Securities and Exchange Commission. All filings are public records.